Jun 08, 2021 7:30am EDT ClearPoint Neuro, Inc. Congratulates BlueRock Therapeutics on First Patient Dosed with DA01 in Phase 1 Study in Patients with Advanced Parkinson’s Disease
May 18, 2021 4:05pm EDT ClearPoint Neuro, Inc. Announces First-in-Human Cases of the SmartFrame Array™ Neuro Navigation System and Software
May 11, 2021 4:05pm EDT ClearPoint Neuro Reports Record Revenue in First Quarter 2021 Results, Announces FDA Clearance of the SmartFrame ‘Array’
May 10, 2021 5:21pm EDT ClearPoint Neuro Announces Partnership With D&K Engineering for Development of Robotic System for the MRI Suite and Operating Room
Apr 28, 2021 4:05pm EDT ClearPoint Neuro, Inc. Congratulates Voyager Therapeutics on FDA Clearance of IND Application for Gene Therapy Candidate VY-HTT01 for Treatment of Huntington’s Disease
Apr 23, 2021 5:00pm EDT ClearPoint Neuro Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)